These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25225661)

  • 1. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.
    Lin RJ; Chu JS; Chien HL; Tseng CH; Ko PC; Mei YY; Tang WC; Kao YT; Cheng HY; Liang YC; Lin SY
    J Immunol; 2014 Oct; 193(8):4159-68. PubMed ID: 25225661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCPIP1 inhibits Hepatitis B virus replication by destabilizing viral RNA and negatively regulates the virus-induced innate inflammatory responses.
    Li M; Yang J; Zhao Y; Song Y; Yin S; Guo J; Zhang H; Wang K; Wei L; Li S; Xu W
    Antiviral Res; 2020 Feb; 174():104705. PubMed ID: 31926181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
    Li M; Yan K; Wei L; Yang Y; Qian Q; Xu W
    Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
    Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
    J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation.
    Lin RJ; Chien HL; Lin SY; Chang BL; Yu HP; Tang WC; Lin YL
    Nucleic Acids Res; 2013 Mar; 41(5):3314-26. PubMed ID: 23355615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.
    Liu S; Zhang Q; Shao X; Wang W; Zhang C; Jin Z
    Int Immunopharmacol; 2017 Sep; 50():87-94. PubMed ID: 28644966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCPIP1 reduces HBV-RNA by targeting its epsilon structure.
    Li Y; Que L; Fukano K; Koura M; Kitamura K; Zheng X; Kato T; Aly HH; Watashi K; Tsukuda S; Aizaki H; Watanabe N; Sato Y; Suzuki T; Suzuki HI; Hosomichi K; Kurachi M; Wakae K; Muramatsu M
    Sci Rep; 2020 Nov; 10(1):20763. PubMed ID: 33247161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.
    Kusakabe S; Suzuki T; Sugiyama Y; Haga S; Horike K; Tokunaga M; Hirano J; Zhang H; Chen DV; Ishiga H; Komoda Y; Ono C; Fukuhara T; Yamamoto M; Ikawa M; Satoh T; Akira S; Tanaka T; Moriishi K; Fukai M; Taketomi A; Yoshio S; Kanto T; Suzuki T; Okamoto T; Matsuura Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
    Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
    Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
    Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
    Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective degradation of plasmid-derived mRNAs by MCPIP1 RNase.
    Qian Y; Li X; Miao R; Liu S; Xin HB; Huang X; Wang TT; Fu M
    Biochem J; 2019 Oct; 476(19):2927-2938. PubMed ID: 31530713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
    J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
    Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
    J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCPIP1/regnase-I inhibits simian immunodeficiency virus and is not counteracted by Vpx.
    Li H; Wang TT
    J Gen Virol; 2016 Jul; 97(7):1693-1698. PubMed ID: 27075251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.